HCW Biologics Inc. (HCWB)
HCWB Stock Price Chart
Explore HCW Biologics Inc. interactive price chart. Choose custom timeframes to analyze HCWB price movements and trends.
HCWB Company Profile
Discover essential business fundamentals and corporate details for HCW Biologics Inc. (HCWB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jul 2021
Employees
36.00
Website
https://www.hcwbiologics.comCEO
Hing C. Wong
Description
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
HCWB Financial Timeline
Browse a chronological timeline of HCW Biologics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Aug 2025
EPS came in at -$6.79 falling short of the estimated $1.80 by -477.22%, while revenue for the quarter reached $6.55K , missing expectations by -6.43%.
Earnings released on 15 May 2025
EPS came in at -$0.05 , while revenue for the quarter reached $5.07K .
Stock split effective on 11 Apr 2025
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Mar 2025
EPS came in at -$3.20 falling short of the estimated $3.60 by -188.89%, while revenue for the quarter reached $394.80K , missing expectations by -94.36%.
Earnings released on 14 Nov 2024
EPS came in at -$0.10 surpassing the estimated -$0.13 by +23.08%, while revenue for the quarter reached $426.42K .
Earnings released on 14 Aug 2024
EPS came in at -$0.40 falling short of the estimated -$0.18 by -122.22%, while revenue for the quarter reached $618.85K .
Earnings released on 1 Apr 2024
EPS came in at -$0.30 falling short of the estimated -$0.15 by -106.90%, while revenue for the quarter reached $1.13M , beating expectations by +25.19%.
Earnings released on 26 Mar 2024
EPS came in at -$0.15 , while revenue for the quarter reached $1.32M .
Earnings released on 14 Nov 2023
EPS came in at -$0.14 falling short of the estimated -$0.13 by -7.69%, while revenue for the quarter reached $853.10K , beating expectations by +42.18%.
Earnings released on 11 Aug 2023
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%, while revenue for the quarter reached $622.81K .
Earnings released on 9 May 2023
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $41.88K , missing expectations by -98.18%.
Earnings released on 28 Mar 2023
EPS came in at -$0.15 falling short of the estimated $0.16 by -193.75%, while revenue for the quarter reached $1.34M .
Earnings released on 7 Nov 2022
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.67%, while revenue for the quarter reached $1.81M .
Earnings released on 12 Aug 2022
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%, while revenue for the quarter reached $454.00K .
Earnings released on 13 May 2022
EPS came in at -$0.06 surpassing the estimated -$0.11 by +45.45%, while revenue for the quarter reached $3.12M , missing expectations by -100.00%.
Earnings released on 29 Mar 2022
EPS came in at -$0.17 falling short of the estimated -$0.12 by -41.67%.
Earnings released on 12 Nov 2021
EPS came in at -$0.14 .
Earnings released on 13 Aug 2021
EPS came in at -$0.08 .
Earnings released on 21 Jul 2021
EPS came in at -$0.08 .
Earnings released on 31 Dec 2020
EPS came in at $0.07 , while revenue for the quarter reached $4.10M .
Earnings released on 30 Sept 2020
EPS came in at -$0.09 .
HCWB Stock Performance
Access detailed HCWB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.